Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

906 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of Prostate-Specific Antigen Screening Pattern on Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White Men: A Large, Urban Health System Cohort Analysis.
Cirulli GO, Davis M, Stephens A, Chiarelli G, Finati M, Corsi N, Williams E, Affas R, Sood A, Buffi N, Lughezzani G, Carrieri G, Salonia A, Briganti A, Montorsi F, Rogers C, Abdollah F. Cirulli GO, et al. Among authors: stephens a. J Urol. 2024 Oct;212(4):560-570. doi: 10.1097/JU.0000000000004118. Epub 2024 Jul 30. J Urol. 2024. PMID: 39079152
Time to second biochemical recurrence as a prognostic indicator in postprostatectomy patients who undergo salvage radiation therapy: An RTOG 9601 based post hoc analysis.
Brodowsky EC, Sood A, Butaney M, Majdalany SE, Stephens A, Corsi N, Piontkowski AJ, Rakic I, Jamil M, Dalela D, Peabody JO, Rogers CG, Abdollah F. Brodowsky EC, et al. Among authors: stephens a. Prostate. 2023 Jan;83(1):64-70. doi: 10.1002/pros.24436. Epub 2022 Sep 19. Prostate. 2023. PMID: 36120850
Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis.
Cirulli GO, Corsi N, Rakic I, Stephens A, Chiarelli G, Finati M, Davis M, Tinsley S, Sood A, Buffi N, Lughezzani G, Carrieri G, Salonia A, Briganti A, Montorsi F, Rogers C, Abdollah F. Cirulli GO, et al. Among authors: stephens a. BJU Int. 2024 May;133(5):555-563. doi: 10.1111/bju.16258. Epub 2024 Jan 8. BJU Int. 2024. PMID: 38097533
Testing the external validity of the POUT III trial (adjuvant platnium-based chemotherapy in upper tract urothelial carcinoma) in a North American cohort.
Corsi NJ, Stephens A, Finati M, Malchow T, Morrison C, Davis M, Hares K, Corsi MP, Arora S, Chiarelli G, Cirulli GO, Autorino R, Sood A, Rogers C, Abdollah F. Corsi NJ, et al. Among authors: stephens a. Urol Oncol. 2024 Jun;42(6):175.e19-175.e25. doi: 10.1016/j.urolonc.2024.01.035. Epub 2024 Mar 23. Urol Oncol. 2024. PMID: 38522975 Clinical Trial.
Adequacy of prostate cancer prevention and screening recommendations provided by an artificial intelligence-powered large language model.
Chiarelli G, Stephens A, Finati M, Cirulli GO, Beatrici E, Filipas DK, Arora S, Tinsley S, Bhandari M, Carrieri G, Trinh QD, Briganti A, Montorsi F, Lughezzani G, Buffi N, Rogers C, Abdollah F. Chiarelli G, et al. Among authors: stephens a. Int Urol Nephrol. 2024 Aug;56(8):2589-2595. doi: 10.1007/s11255-024-04009-5. Epub 2024 Apr 2. Int Urol Nephrol. 2024. PMID: 38564079
Race has no impact on prostate cancer-specific mortality, when comparing patients with similar risk of other-cause mortality: An analysis of a population-based cohort.
Tinsley SA, Finati M, Stephens A, Chiarelli G, Cirulli GO, Williams E, Morrison C, Richard C, Hares K, Sood A, Buffi N, Lughezzani G, Bettocchi C, Salonia A, Briganti A, Montorsi F, Carrieri G, Rogers C, Abdollah F. Tinsley SA, et al. Among authors: stephens a. Cancer. 2024 Sep 15;130(18):3157-3169. doi: 10.1002/cncr.35386. Epub 2024 May 28. Cancer. 2024. PMID: 38804713
906 results